{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-012573","form_type":"8-K","ticker":"SFES","cik":"0000086115","company_name":"SAFEGUARD SCIENTIFICS INC","filed_at":"2023-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.459167+00:00","generated_at":"2026-06-15T23:46:49.821770+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Safeguard Scientifics Q1 net loss narrows to $3.5M; in advanced deal talks","bullets":["Net loss $3.5M ($0.22/sh) vs $6.7M loss in Q1 2022; cash $18.8M.","Sold Bright Health interest for $850k; deployed $3.0M to Prognos post-Q1.","Reduced FY2023 deployment expectation to $3.0-4.5M from $4.0-6.0M.","Advanced discussions with single counterparty for strategic transaction; no deal yet.","G&A $1.2M and corporate expenses $0.8M, down 4-6% YoY."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-012573","json":"https://secwatch.observer/filing/0001437749-23-012573.json","markdown":"https://secwatch.observer/filing/0001437749-23-012573.md","text":"https://secwatch.observer/filing/0001437749-23-012573.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/86115/000143774923012573/0001437749-23-012573-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/86115/000143774923012573/sfe20230503_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T23:46:49.821770+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"77ea4f346e0aea7d5afd7b087830d477b774bbfc","claim":"SAFEGUARD SCIENTIFICS INC reported the three months ended March 31, 2023 results: net income Net loss for the three months ended March 31, 2023 was $3.5 million, or $0.22 per share, EPS $0.22 per share. Guidance reaffirmed.","evidence_excerpt":"Safeguard Scientifics, Inc. (NASDAQ:SFE) (“Safeguard” or the “Company”) today announced financial results for the three months ended March 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/86115/000143774923012573/0001437749-23-012573-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended March 31, 2023"},{"label":"Net income","value":"Net loss for the three months ended March 31, 2023 was $3.5 million, or $0.22 per share"},{"label":"EPS","value":"$0.22 per share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}